NCT06658353RecruitingPhase 3
Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
Single-arm, Open, Multi-center Phase III Clinical Study to Assess the Safety and Effectiveness of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
Source: ClinicalTrials.gov · Last updated 27 Jul 2026
Brief summary (registry, in English)
This Study is a single arm, open label, multicenter phase III clinical trial to evaluate the safety and efficacy of VC004 in patients with locally advanced/metastatic solid tumors.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- First submitted
- 24 Oct 2024
- Start date
- 17 Mar 2025
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Diseases
- Childhood cancers
- NCT number
- NCT06658353
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 54
- From 17 Mar 2025 to the primary completion date, 30 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients have undergone major surgery within 4 weeks prior to the first dose or are expected to undergo major surgery during the trial (excluding vascular access establishment procedures, biopsy procedures);
- Adverse reactions caused by previous treatment have not recovered to ≤1 grade (evaluated by the investigator);
- Patients had been treated with a strong CYP3A inhibitor or inducer within 7 days prior to the first administration of the study drug.
Who the study is looking for
- All subjects or legal representatives are willing and able to sign ICF approved by the ethics committee before starting any screening procedures；
- Male or female, age ≥12 years old;
Age in the registry: 12 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| cancer hospital， Chinese Academy of medical sciences and Peking union medical college Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.